Tuesday, July 14, 2020 1:01:11 AM
Very robust outcomes, imo.
$EQ
Disclosure: all Imho only, do your own DD.
Recent EQ News
- Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights • Business Wire • 03/25/2024 08:01:00 PM
- Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference • Business Wire • 03/22/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:35:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:01:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 10:12:11 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/23/2024 10:09:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 11:08:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 11:17:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 11:14:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 11:12:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 01:05:52 PM
- Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease • Business Wire • 12/21/2023 01:00:00 PM
- EQ Bank Card launches in Québec as Carte Banque EQ • PR Newswire (Canada) • 11/20/2023 04:23:00 PM
- EQ Bank Card launches in Québec as Carte Banque EQ • PR Newswire (US) • 11/20/2023 04:23:00 PM
- Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology • Business Wire • 11/13/2023 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:10:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:05:10 PM
- Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates • Business Wire • 11/08/2023 09:01:00 PM
- Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology • Business Wire • 11/06/2023 01:00:00 PM
- Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology • Business Wire • 10/19/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 12:05:52 PM
- Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium • Business Wire • 10/16/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 09:28:30 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/05/2023 09:23:38 PM
- Equillium to Host Analyst & Investor Day • Business Wire • 10/03/2023 12:00:00 PM
FEATURED POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • Mar 27, 2024 10:52 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM